Michael Aronchik
Overview
Explore the profile of Michael Aronchik including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
3
Citations
45
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Izzy S, Yahya T, Albastaki O, Abou-El-Hassan H, Aronchik M, Cao T, et al.
Nat Neurosci
. 2025 Feb;
28(3):499-516.
PMID: 40016353
Neuroinflammation plays a crucial role in traumatic brain injury (TBI), contributing to both damage and recovery, yet no effective therapy exists to mitigate central nervous system (CNS) injury and promote...
2.
Brandao W, Jain N, Yin Z, Kleemann K, Carpenter M, Bao X, et al.
Sci Transl Med
. 2025 Jan;
17(781):eadk3690.
PMID: 39813317
Alzheimer's disease (AD) is the most prevalent neurodegenerative disorder. Antiamyloid antibody treatments modestly slow disease progression in mild dementia due to AD. Emerging evidence shows that homeostatic dysregulation of the...
3.
Izzy S, Yahya T, Albastaki O, Cao T, Schwerdtfeger L, Abou-El-Hassan H, et al.
Brain Commun
. 2024 Jul;
6(4):fcae147.
PMID: 39045090
The associations between human concussions and subsequent sequelae of chronic neuropsychiatric and cardiovascular diseases such as hypertension have been reported; however, little is known about the underlying biological processes. We...
4.
Rosenzweig N, Kleemann K, Rust T, Carpenter M, Grucci M, Aronchik M, et al.
Nat Med
. 2024 Jul;
30(10):2990-3003.
PMID: 38961225
APOE4 is the strongest genetic risk factor for Alzheimer's disease (AD), with increased odds ratios in female carriers. Targeting amyloid plaques shows modest improvement in male non-APOE4 carriers. Leveraging single-cell...
5.
Yin Z, Rosenzweig N, Kleemann K, Zhang X, Brandao W, Margeta M, et al.
Nat Immunol
. 2023 Sep;
24(11):1839-1853.
PMID: 37749326
The APOE4 allele is the strongest genetic risk factor for late-onset Alzheimer's disease (AD). The contribution of microglial APOE4 to AD pathogenesis is unknown, although APOE has the most enriched...